| Date Filed | Type | Description |
| 07/06/2007 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/27/2007 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in BioVeris Corporation |
| 06/26/2007 |
8-K
| Quarterly results |
| 06/21/2007 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 4% stake in BioVeris Corporation |
| 06/18/2007 |
8-K
| Other Events |
| 06/14/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/11/2007 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 3.6% stake in BioVeris Corporation |
| 06/07/2007 |
10-K
| Annual Report for the period ended March 31, 2007 |
| 06/04/2007 |
SC 13D
| GAMCO INVESTORS, INC. ET AL reports a 2.8% stake in BioVeris Corporation |
| 05/21/2007 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 05/18/2007 |
8-K
| Entry into a Material Definitive Agreement |
| 05/15/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 05/10/2007 |
SC 13D/A
| ROCHE HOLDING LTD reports a 19.3% stake in 1 )* BioVeris Corporation |
| 05/03/2007 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 04/13/2007 |
SC 13D
| ROCHE HOLDING LTD reports a 21.3% stake in BioVeris Corporation |
| 04/10/2007 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Agreement and Plan of Merger by and among Roche Holding Ltd, Lili Acquisition Corporation and BioVeris Corporation",
"Vaccines Asset Transfer Agreement between BioVeris Corporation and 32 Mott Street Acquisition I, LLC",
"ECL Asset Transfer Agreement between BioVeris Corporation and 32 Mott Street Acquisition II, LLC",
"ECL License Agreement between BioVeris Corporation and 32 Mott Street Acquisition II, LLC",
"Amendment to BioVeris Termination Protection Program",
"BioVeris Severance Plan",
"Non-Disclosure and Non-Solicitation Agreement between BioVeris Corporation and Samuel J. Wohlstadter",
"Transaction Agreement between Samuel J. Wohlstadter and Roche Holding Ltd",
"Stockholders Agreement between Roche Holdings Ltd, Samuel J. Wohlstadter and Nadine Wohlstadter" |
|
| 04/04/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 04/04/2007 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/20/2007 |
SC 13G/A
| KLEINBERG KAPLAN WOLFF & COHEN P C reports a 8.2% stake in BioVeris Corporation |
| 02/12/2007 |
SC 13G/A
| ROYCE & ASSOCIATES LLC reports a 3.4% stake in Bioveris Corporation |
| 02/09/2007 |
8-K
| Results of Operations and Financial Condition |
| 02/06/2007 |
10-Q
| Quarterly Report for the period ended December 31, 2006 |
| 01/26/2007 |
8-K
| Other Events |
| 01/08/2007 |
8-K
| Other Events |
| 12/27/2006 |
8-K
| Other Events |
| 11/06/2006 |
10-Q
| Quarterly Report for the period ended September 30, 2006 |
| 10/13/2006 |
8-K
| Entry into a Material Definitive Agreement |
| 08/09/2006 |
10-Q
| Quarterly Report for the period ended June 30, 2006 |
| 07/28/2006 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 06/21/2006 |
8-K
| Entry into a Material Definitive Agreement |
| 06/14/2006 |
10-K
| Annual Report for the period ended March 31, 2006 |
| 05/11/2006 |
SC 13G
| KLEINBERG KAPLAN WOLFF & COHEN P C reports a 5.4% stake in BioVeris Corporation |
| 02/10/2006 |
10-Q
| Quarterly Report for the period ended December 31, 2005 |
| 01/25/2006 |
SC 13G/A
| DEUTSCHE BANK AG\ reports a 5% stake in Common Stock TITLE OF CLASS OF SECURITIES 090676107 CUSIP NUMBER December 30, 2005 Check the appropriate box to designate the rule which this Schedule is filed: [ x ] Rule 13d- |
|